Document is current
Any future updates will be listed below
-
Authors
Chen, Chong-xiang https://orcid.org/0000-0002-2079-881X
Hu, Fang
Wei, Jin
Yuan, Le-tao https://orcid.org/0000-0002-1268-8135
Wen, Tian-meng
Gale, Robert Peter https://orcid.org/0000-0002-9156-1676
Liang, Yang https://orcid.org/0000-0002-4226-9580
- License Information
-
More Information
Article History
Received: 25 November 2020
Revised: 8 April 2021
Accepted: 26 April 2021
First Online: 17 May 2021
Compliance with ethical standards
:
: RPG is a consultant to: BeiGene Ltd., Fusion Pharma LLC, LaJolla NanoMedical Inc., Mingsight Parmaceuticals Inc. and CStone Pharmaceuticals. Advisor: Antegene Biotech LLC, Medical Director: FFF Enterprises Inc. Partner: AZACA Inc. Board of Directors: RakFond Foundation for Cancer Research Support. Scientific Advisory Board, StemRad Ltd. All other authors declare no competing interests.
